Buscar

Limitar los resultados
Buscar
Usar mi ubicación actual
Buscar

Mes del evento

Tipo de servicio

Costo

Categoría del evento

Etiqueta

Número de resultados encontrados: 26
Use esta navegación adicional para ir a las páginas siguientes. Use las teclas de tabulación e Intro para navegar por el menú1 Página n.º 2 Página n.º 3 Navegar a la página siguiente Página 1 de 3
Saltee a 26 resultados encontrados. Página 1 de 3
    • Martes, 20 de abril de 2021

    Investigadores de Renown buscan participantes en el estudio de plasma de convaleciente

    Los médicos investigadores tratan de entender cómo responde el sistema inmunitario a la COVID-19 y crear un Nevada más saludable. Durante las primeras fases de la pandemia, el plasma de convalecencia se consideraba la única opción de tratamiento viable disponible para los pacientes con COVID-19. El plasma de convaleciente es el componente de la sangre de los pacientes recuperados que puede contener anticuerpos de COVID-19 que ayudan a combatir la infección. Desde entonces, los Institutos Nacionales de la Salud han elaborado directrices de tratamiento para la COVID-19 basadas en los datos de los estudios clínicos, y todavía se están realizando muchos estudios en todo el mundo que evalúan diversas opciones de tratamiento adicionales. El plasma de convaleciente tenía una gran demanda pero era difícil de localizar para los pacientes con COVID-19 en la zona del norte de Nevada. Austin Meegan, un auxiliar de enfermería de 24 años, fue hospitalizado y pasó semanas evitando la insuficiencia renal y pulmonar antes de enterarse de que cumplía los requisitos para recibir una transfusión de sangre experimental que parecía prometedora para el tratamiento de la COVID-19. Los médicos estimaron que Meegan solo tenía un 3 % de posibilidades de encontrar un donante compatible con su raro tipo de sangre. Thomas Gibson, un sobreviviente de la COVID-19 y residente de Texas con el mismo tipo de sangre, viajó a Reno para donar sus anticuerpos víricos y realizar una donación de plasma de convaleciente, la cual se cree que ayudó a salvar la vida de Meegan. Los investigadores clínicos y los científicos de Renown y de la Facultad de Medicina de la Universidad de Nevada, Reno (UNR Med) sabían que necesitaban crear mejores opciones para los pacientes y los médicos. Los investigadores clínicos desarrollaron un estudio para ayudar a otros pacientes como Austin, y solicitaron donaciones de pacientes recuperados de COVID-19 para que donaran su plasma de convaleciente. Los equipos de investigadores trataron de entender cómo responde el sistema inmunitario del cuerpo al virus a lo largo del tiempo, para ayudarles a desarrollar nuevos tratamientos para la COVID-19. “La capacidad del mundo para atravesar la crisis de la COVID dependerá de cuatro cosas: ciencia, tecnología, innovación y asociaciones”, dice el Dr. Tony Slonim, DrPH, presidente y director ejecutivo de Renown Health. “La capacidad del mundo para superar la crisis de la COVID dependerá de cuatro elementos: ciencia, tecnología, innovación y asociaciones, pero con UNR Med y nuestros socios, estamos haciendo grandes progresos en el avance de la investigación clínica que tiene el poder de salvar vidas y crear un estado de Nevada más saludable”. “Es tremendamente prometedor colaborar en la investigación clínica que no solo nos ayudará a entender mejor la enfermedad, sino que también ayudará a informar sobre el tratamiento para aquellos que combaten el COVID-19 que ha tenido un impacto tan devastador en los nevadenses, en nuestro país y en el mundo”, afirma Dean Thomas L. Schwenk, MD, de UNR Med. Renown, UNR Med y otros socios de atención médica del área colaboraron con Vitalant para recolectar plasma de donantes recuperados para un estudio sobre la eficacia del tratamiento. Los donantes elegibles tenían al menos 18 años, pesaban más de 110 libras y estaban sanos. Los donantes se habían recuperado completamente de un diagnóstico confirmado de COVID-19. Los coordinadores del proyecto en la Oficina de Investigación de Renown se vieron abrumados por el apoyo de la comunidad y las donaciones de plasma. Las asociaciones adicionales con el Distrito de Salud del Condado de Washoe, el estado de Nevada y la Oficina del Gobernador, Saint Mary’s Medical Center, Northern Nevada Medical Center, Carson Tahoe Health y VA Sierra Nevada Health Care System, junto con muchos proveedores de atención médica del área, ayudaron al equipo a alcanzar sus objetivos de inscribir a 120 participantes elegibles en el estudio. “Nuestro éxito en este estudio depende en gran medida del apoyo de nuestra gran comunidad, así como de la innovación y la colaboración demostradas por Renown y UNR Med”, afirmó Sara Healy, MD, MPH, investigadora principal del estudio y médica de enfermedades infecciosas pediátricas en Renown Children’s Hospital y UNR Med. “Estamos orgullosos de estar a la vanguardia respecto de la realización de investigaciones esenciales durante un tiempo tan importante de la historia, y esperamos que nuestra asociación se prolongue en el tiempo a medida que continuamos con esta importante labor”. “El control de la COVID-19 en nuestras comunidades depende de las pruebas. El estudio, que se está realizando para desarrollar una forma sensible, específica y más sencilla de recoger muestras (sangre), está avanzando en este campo y promete alcanzar nuestro objetivo común de tener la prueba de diagnóstico correcta para la situación clínica correcta en el momento correcto”, explica Mark Riddle, MD, DrPH, FISTM, investigador asociado del estudio, decano asociado de Investigación Clínica y profesor del Departamento de Medicina Interna e Investigación Médica de UNR Med. El equipo de investigación pide ahora a los residentes del área que participen en un estudio para analizar la eficacia de dos pruebas de detección de la COVID-19. Los participantes se someterán a dos análisis de sangre: uno de ellos consiste en una punción digital para obtener los resultados de una prueba rápida, y el otro consiste en una venopunción tradicional que confirma la presencia o ausencia de anticuerpos contra la COVID-19. Este estudio es una colaboración con InBios International, Inc. una empresa líder en biotecnología con sede en Seattle. Los investigadores buscan: Personas que han dado positivo para COVID-19 y que se han recuperado recientemente del virus. Los participantes del estudio deben estar en un período de entre 7 y 28 días posteriores al inicio de sus síntomas. Personas que recientemente hayan dado negativo para COVID-19 y nunca hayan dado positivo. Los interesados en participar en el estudio pueden ponerse en contacto con los coordinadores del proyecto en la Oficina de Investigación de Renown al (775) 982-3646, o por correo electrónico a covidplasmascreening@renown.org, de lunes a viernes, de 7:30 a.m. a 5:00 p.m. Se anima a las personas de entre 18 y 75 años con buena salud en general a que consideren la posibilidad de participar en este estudio en curso. No hay costo alguno por participar en este estudio y la participación es voluntaria. Su decisión de participar no afectará sus relaciones actuales o futuras con sus proveedores de atención médica, con el distrito de salud ni con la comunidad. Aquellos que decidan participar son libres de retirarse en cualquier momento. “El tiempo es vital cuando se trata de la COVID-19. Si podemos entregar los resultados de las pruebas a las personas y sus médicos de manera más oportuna, podremos hacer un diagnóstico más rápido del estado de salud de un paciente”, explica Christopher M. Kozlowski, MD, MHA, funcionario de Investigación Institucional de Renown y director médico/vicepresidente del Renown Institute for Heart & Vascular Health. “A medida que perfeccionamos la precisión de nuestras pruebas, aplicamos las pruebas de sensibilidad y especificidad para obtener resultados verdaderos negativos y verdaderos positivos. Esto proporciona a las personas resultados más oportunos y precisos y una atención de calidad mejorada”.     Acerca de Renown Health Renown Health es una red de atención médica integrada de administración local y sin fines de lucro que brinda servicios al norte de Nevada, Lake Tahoe y el noreste de California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. Abarca tres hospitales de cuidados intensivos, un hospital de rehabilitación, el grupo médico y la red de atención de urgencias más integrales del área, y la compañía de seguro sin fines de lucro de propiedad local más grande de la región, Hometown Health. Renown tiene una larga trayectoria y un compromiso de larga data con la mejora de la atención y la salud de nuestra comunidad.     Acerca de la Facultad de Medicina de la Universidad de Nevada, Reno La Facultad de Medicina de la Universidad de Nevada, Reno (UNR Med), la primera facultad de medicina pública de Nevada, es una facultad basada en la comunidad, con un gran énfasis en la investigación y una visión a nivel estatal de un estado de Nevada saludable. Fundada en 1969, la UNR Med está mejorando la salud y el bienestar de todos los residentes de Nevada y sus comunidades mediante excelencia en la educación estudiantil, capacitación de posgrado y atención clínica, investigación con impacto local, nacional y global y una cultura de diversidad e inclusión. Para obtener más información, visite med.unr.edu.

    Leer más Acerca de Investigadores de Renown buscan participantes en el estudio de plasma de convaleciente

    • Miércoles, 05 de octubre de 2022

    Centro de Investigación Clínica recientemente ampliado en UNR Med fomenta la colaboración y la investigación con Renown Health

    Renown Health y University of Nevada, Reno School of Medicine (UNR Med) se enorgullecen en anunciar un espacio de investigación recientemente integrado y ampliado llamado Centro de Investigación Clínica (Clinical Research Center, CRC). Este espacio ofrece una ubicación física dinámica en el campus de la Universidad de Nevada, Reno, que apoya a la empresa de investigación UNR Med y Renown Health. “La asociación entre Renown Health y UNR Med realmente no conoce límites, y este Centro de Investigación Clínica es un ejemplo increíble de esa infinita posibilidad”, dijo Thomas Graf, MD, director ejecutivo interino de Renown Health. “Este nuevo espacio solo continuará expandiendo el acceso de nuestra comunidad a la investigación clínica como parte de la atención al paciente mientras proporciona los recursos necesarios para involucrar a nuestros estudiantes y apoyar un Nevada saludable”. Las capacidades de este espacio incluyen personal experimentado con conocimientos y habilidades en la puesta en funcionamiento de estudios de investigación clínicos y traslacionales no regulados por la FDA en una clínica de investigación centralizada de 5,470 pies cuadrados ubicada en el Centro de Medicina Molecular (Center for Molecular Medicine, CMM) de la Universidad. Este espacio de CRC proporciona recursos que incluyen: Una ubicación centralizada junto al espacio de laboratorio que permite la colaboración interdisciplinaria estratégica entre médicos y científicos básicos. Once habitaciones privadas para pacientes ambulatorios para visitas a la clínica de investigación. Dos estaciones de extracción de sangre. Áreas de consulta con el médico. Sala de conferencias para monitoreo y consultoría de ensayos. Asegurar el almacenamiento y la preparación del producto en investigación. Procesamiento y almacenamiento de muestras, incluidas centrífugas refrigeradas de encimera, refrigeradores y congeladores de 4°, -20° y -80° C. Las operaciones en torno a la investigación clínica se están volviendo más complejas, por lo que el crecimiento de la investigación clínica en nuestra comunidad requerirá experiencia y un espacio dedicado donde la investigación clínica se pueda realizar primero en un entorno de aprendizaje”, dijo Danielle Eaton, directora de Investigación Clínica de UNR Med y Renown Health. “Este centro de investigación clínica proporciona dicho espacio y personal experimentado donde estos estudios de investigación pueden completarse con éxito. El CRC proporciona un entorno de capacitación para estudiantes, residentes, cuerpo docente y personal profesional de investigación clínica que será necesario para llevar diagnósticos, tratamientos y preventivos de vanguardia a nuestra comunidad”. Conozca al equipo: Danielle Eaton, Directora médica de investigación clínica de UNR, Kristen Gurnea, Gerente de Investigación Clínica de Renown Health, Amber Emerson, Valerie Smith, gerente de proyectos de UNR Med, Annie Beach-Hills, gerente administrativa del UNR Med Center, Gina Castro, Michelle Mejia y Amil Trujillo-King, Coordinadores del estudio de UNR Med, Dr. John Westhoff, Presidente de Medicina Interna de UNR Med, Médico de medicina de emergencia, Dr. Sean Kandel, UNR Med Director asociado del programa de investigación para residentes, Profesor adjunto de Medicina Interna, Dr. Amneet Rai, Farmacéutica de investigación clínica de UNR Med, Dra. Kellie Watkins, Epidemiólogo clínico/gerente de datos/estadístico de UNR Med Como parte de la afiliación entre UNR Med y Renown Health, la Oficina de Investigación Clínica es parte de una Oficina de Investigación Clínica integrada, lo que permite que ambas entidades colaboren en los objetivos compartidos del programa de investigación. Este esfuerzo permite que los colegas se asocien en investigaciones clínicas y aprovechen la investigación y la prestación de atención médica de vanguardia a los nevadenses del norte. Acerca de Renown Health Renown Health es la red de atención médica integrada de administración local y sin fines de lucro más grande de la región, que presta servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. Acerca de UNR Med La Universidad de Nevada, Reno School of Medicine (UNR Med), la primera escuela de medicina pública de Nevada, es una escuela de medicina comunitaria intensiva en investigación con una visión estatal para una Nevada saludable. Desde 1969, UNR Med ha capacitado a más de 3,900 estudiantes, residentes y becarios. La UNR Med continúa mejorando la salud y el bienestar de todos los residentes de Nevada y sus comunidades mediante excelencia en la educación estudiantil, capacitación de posgrado y atención clínica, investigación con impacto local, nacional y global, y una cultura de diversidad e inclusión. Para obtener más información, visite med.unr.edu.

    Leer más Acerca de Centro de Investigación Clínica recientemente ampliado en UNR Med fomenta la colaboración y la investigación con Renown Health

  • Atención médica para pacientes terminales

    Compassionate Care in the Comfort of Your Home Welcome to Renown Hospice, where compassion meets comfort in life’s most tender moments. Renown Hospice is a not-for-profit hospice, founded solely on a mission to care for and support those in our community. With a dedicated team of professionals and comprehensive services provided in the comfort of your home, our hospice program is one of the highest-rated quality care and experience agencies in northern Nevada.

    Read More About Hospice Care

    • Directiva anticipada
    • Atención de apoyo y cuidados paliativos
    • Atención médica para pacientes terminales

    Aquí le mostramos cómo conmemorar el Día Nacional de la Decisión sobre la Atención Médica

    National Healthcare Decision Day is forthcoming. Here’s an easy and free way to commemorate the occasion: openly discussing how we want to be cared for at the end of our lives. Join Renown Health’s experts at a workshop about making decisions about an advance directive. Among the random national holidays, this one has significance: April 16 is National Healthcare Decision Day. And experts agree that the best time to discuss your views about end-of-life care and to learn what choices are available is before a life-limiting illness or crisis occurs. By preparing in advance, you can help reduce the doubt and anxiety related to decision making for your family if you cannot speak for yourself. “Completing your advance directive is a gift you give your family,” says Mary-Ann Brown, RN, MSN, director of Palliative Care. “The stress associated with these difficult decisions is decreased if everyone knows what is important to you and what you want the end of life.” What Are Advance Directives? An advance directive is a document that states your choices about medical treatment and names another person to make medical decisions on your behalf if you are unable to. This document allows you to make legally valid decisions about future medical care. Find more information about advance directives and the form online. The Conversation The first step in completing an Advance Directive is to think about what’s important to you and talk to your loved ones. The Conversation Project provides helpful tools to guide you and your family through this challenging topic. Getting this information together will help you fill out and complete your advance directives. Some things to consider and discuss with your family include: When you think about the last phase of your life, what’s most important to you? Who do you want involved in your care? Who should make decisions on your behalf if you’re not able to? Where do you want or not want to receive care? Are there specific treatments you would or would not want? Complete Your Advance Directive Planning In order to complete an advance directive, you will need either two witnesses or a notary to sign the form. Be sure to note restrictions on the witness process. When an advance directive is complete, you should keep the original. Copies should be given to your agent named in the form, your family, your doctor(s) and the location that you receive care. Renown Health offers four advance directive workshops every month to cover the details of filling out this document. A healthcare team is available to answer questions and work through the process with you. A notary is also present to finalize the process, which means you can complete your advanced directives during this workshop. Find the workshop by calling 775-982-RSVP for more information. Advance Care Planning Workshop April 17, 1-2:30 p.m. | Free Join Renown Health’s experts for a workshop about making decisions regarding end-of-life care. You will learn how to fill out an advance directive, receive one-on-one assistance and have your documents signed by a notary. Workshops are typically held several times each month. To RSVP, call 775-982-7787

    Read More About Here's How to Commemorate National Healthcare Decision Day

    • Atención del cáncer
    • Ensayos clínicos
    • Investigación y estudios

    Sobreviviente del cáncer de ovario cuenta cómo decidió probar con ensayos clínicos

    While there used to be three basic treatment options for cancer -- surgery, radiation and chemotherapy, or a combination of the three -- there's a fourth option: clinical trials. Here, a Renown patient shares her successful battle with ovarian cancer, aided by a clinical trial. Shari Flamm's battle with ovarian cancer began in 2011. She was experiencing prolonged bleeding, irregular thyroid levels and anemia and was scheduled to undergo a hysterectomy. Before the surgery, her gynecologist ran routine tests to check for cancer as a precautionary measure. All tests were negative for cancer, expect her CA 125 test. A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in the blood. In some cases, a CA 125 test may be used to look for early signs of ovarian cancer in women with a very high risk of the disease. In most laboratories, the normal level is 0 to 35 units/ml. Flamm's CA 125 level was 121. As Flamm can attest, early diagnosis played a key role in her battle with ovarian cancer. September is Gynecologic Cancer and Ovarian Cancer Awareness Month – an important time to learn the signs, symptoms and risk factors of this type of cancer so your doctor can diagnosis the disease as early as possible. Ovarian Cancer: Round One Despite the elevated CA 125 results, her doctor recommended they move forward with the hysterectomy. But when surgery began, doctors discovered a mass. She had stage 4 cancer. The procedure was halted, the mass was biopsied and she was immediately seen by Dr. Peter Lim of the The Center of Hope. Following diagnosis, Flamm underwent surgery with Dr. Lim to remove the cancer, which had spread to part of diaphragm, spleen, colon and other organs. Three months after surgery, Flamm had recovered enough to start six rounds of chemotherapy in her hometown of Carson City. She continued working at a doctor's office during her treatment, and was grateful for Dr. Lim’s ability to co-manage her care so she could stay close to work and family. “To me, chemo was the scariest part because I didn’t like feeling sick,” Flamm says. Thankfully, her body responded well to the treatments and she was back to the things she loved. “I stated working out at the gym, even if it was only for 10 minutes,” she says. She also stayed positive by spending time with her grandchildren, attending a San Jose Sharks hockey game, going for walks and enjoying concerts. Ovarian Cancer: Round Two In November 2014, Flamm had a cancer check-up. That’s when doctors discovered three cancerous tumors. For this round, Flamm choose another treatment option -- clinical trials at Renown Institute for Cancer. Clinical trials are the studies that test whether drugs work, and inform doctors' decisions about how to treat their patients. Flamm participated in a clinical trial that featured oral-targeted therapy stronger than IV chemotherapy. The hope was for the drug to shrink her tumors, however the result was stabilization -- meaning the lumps weren’t growing or spreading. The best part of the clinical trial, Flamm says, was the constant monitoring. Between the CT scans every six weeks, a heart scan every three months and monthly doctor visits, she was confident that if the cancer started growing or spreading, her healthcare team would catch it right away. For Flamm, the benefits of the clinical trial included less hair loss, less fatigue and more time to focus on what’s important in her life -- her family. “I decided I wasn’t going to be that sick grandma on the couch with cancer,” Flamm says. After taking the oral medication for one year, Flamm developed a rash and discontinued treatment due to discomfort. Clinical Trials, Setbacks and Survival In June 2016, two of the three tumors began to grow and had to be surgically removed. Despite the setback, Flamm was determined to maintain a positive outlook. "You have to stay positive because cancer feeds off anger, depression and stress," Flamm says. Flamm was released to go home with clear margins, meaning the tumors were removed and are surrounded by a rim of normal tissue that does not have cancerous cells. Flamm says her outlook on life has changed drastically since her first cancer diagnosis. “Your whole mentality changes when cancer disturbs your life," Flann says. "The things that weren’t important, are now ever so important. I’m a lot calmer now,” Flamm says.

    Read More About Ovarian Cancer Survivor Shares Decision to Try Clinical Trial

    • Farmacia
    • Consumo de drogas
    • Medicamentos

    Medicamentos genéricos: lo que debe saber sobre ellos

    Without a doubt, taking medications can not only be expensive, but also confusing. In the United States, generic prescriptions are widely used, with 9 out of 10 people choosing them over a name brand. Pharmacists are a great resource to help us understand the benefits and side effects of any medication. We asked Adam Porath, PharmD, Vice President of Pharmacy at Renown Health, to answer some common questions about generic drugs. What is a generic drug? A generic drug has the same active ingredients of brand-name drugs. Brand-name drugs have a patent (special license) protecting them from competition to help the drug company recover research and development costs. When the patent expires other manufacturers are able to seek approval for a generic drug. However, the color, shape and inactive elements may be different. Per the U.S. Food & Drug Administration (FDA), a generic medicine works in the same way and provides the same clinical benefit as its brand-name version. Why do they cost less? Generic drug makers do not have the expense of costly development, research, animal and human clinical trials, marketing and advertising. This savings is passed on to the public. Also after a patent expires, several companies will compete on a generic version of a drug, further driving down prices.

    Read More About Generic Drugs – What You Need to Know About Them

    • Fundación de Renown Health
    • Directiva anticipada

    Errores de planificación patrimonial que se deben evitar

    August is National Make-a-Will month. We talked to Renown Health Foundation Planned Giving Officer, Abbey Stephenson, to learn more about wills, trusts, and estate plans and why you should feel motivated this month to get started. Did you know that 2/3 of Americans don't have a will or trust? If this is you, don’t worry, you’re not alone. Although there are laws in place to determine who inherits your assets if you die without a will or trust, having a will or trust ensures your assets go where you want them to go after you are gone. They can also help minimize disputes between family members and heirs about who gets what. In Nevada, the laws that govern who gets what if you die without a will or trust can be found in Chapter 134 of the Nevada Revised Statutes. There are other documents that people often prepare at the same time as their will or trust – like an advance health care directive and durable power of attorney for assets. These documents all together are called an estate plan. Although they have other purposes too (like nominating a guardian for a child, planning for disability or avoiding probate, which is a court process), wills and trusts are documents that say who will receive your assets after you are gone. The most common type of trust is often called a revocable living trust or a family trust. People who have a trust usually still have a will, although it is a shorter form of will called a pour-over will. It’s a good idea to talk to an estate planning attorney about whether or not a trust makes sense for your family or circumstances.  Now that you’re ready to get started, here are some mistakes to avoid: 1. Failing to plan Not setting aside the time to plan may be the biggest mistake. Failing to prioritize preparing or updating your estate plan means your last wishes and desires may not be fulfilled. The right documents memorialize what you would like to happen upon your disability and death so that other people can know and follow your wishes with respect to your care and your assets.  2. Failing to coordinate beneficiary designations Certain types of assets like life insurance and retirement accounts are not covered by your will or trust and need to be addressed separately. These types of assets are referred to as non-probate assets because they transfer under contract principles and don’t require court supervision or probate to be distributed to the named beneficiaries. By completing beneficiary designation forms provided by the retirement account custodian, insurance company or financial institution, you can direct your assets to one or more beneficiaries. 3. Failing to title your assets properly Asset titling refers to how you own your asset – such as in your individual name, jointly with someone else, or in a trust or entity. For example, assets titled for two people with a “right of survivorship” will automatically go to the surviving owner. Review your asset titling and make changes, if needed, to ensure your property and assets are passed down the way you intend. 4. Failing to include charities meaningful to you In addition to providing for family members and other important people in your life, you many also choose to give to charities meaningful to you in your estate plan. When you include a charity in your estate plan, that gift is called a planned gift and many charitable organizations, including Renown, recognize such donations through their legacy giving societies. As you prepare to make your own will or a more comprehensive estate plan, we recommend you consult with a lawyer. Here are some free resources that may be helpful too:  Renown Health Foundation is proud to sponsor the Family Estate Planning Series put on by PBS Reno and the Community Foundation of Northern Nevada. The free, 8-week course of 90-minute, in-depth workshops is a great place to learn much more and to help you get started in the planning process. The next course begins on September 7, 2022. More information can be found here. Renown Health offers periodic advance health care directive workshops where attendees can learn about, complete, and sign their directive. The next workshop is scheduled for September 14th. More information can be found here. The American College of Trust and Estate Counsel provides information on a number of commonly asked estate planning questions here. If you are interested in including a charitable gift to Renown in your estate plan, we would be happy to talk to you about how your gift will make a difference for our mission. Please contact Abbey Stephenson at abbey.stephenson@renown.org or visit renown.org/LegacyGiving to learn about Renown Health Foundation’s Legacy Giving Society and ways to give.

    Read More About Estate Planning Mistakes to Avoid

    • Ensayos clínicos
    • Investigación y estudios

    ¿Qué significa participar en un estudio clínico?

    Participating in a clinical trial is voluntary and a personal choice. Clinical trials are research studies that involve people and are an important part of patient care. What is a clinical trial?  Clinical trials are research studies that involve people, and they are an important part of patient care. There are several different types of clinical trials; some are designed to understand trends in a disease or identify better ways to diagnose a condition, while others determine if a new treatment is safe and works when treating, improving or preventing a health condition. There are over 400,000 clinical trials currently being conducted in the United States, and even more across the world. This includes health conditions such as heart failure, cancer, Parkinson’s Disease, respiratory conditions like COPD, common infections, cystic fibrosis, and many more. Clinical trials lead the healthcare industry to new discoveries that contribute to reliable and exact care, improving healthcare quality and saving lives. Clinical trials are conducted by a team of researchers, including doctors, pharmacists and clinical research coordinators. These research teams are highly skilled in their specialty areas, often providing traditional patient care and seeing research patients in the same day. These teams are responsible for making sure the clinical trial is completed correctly, and their patients are their top priority. Why should I consider participating in a clinical trial? Participating in a clinical trial is voluntary and a personal choice. There are many reasons why patients decide to get involved in clinical research. While many clinical trials are designed for patients who have a certain health condition, many studies also ask healthy volunteers to contribute in order to compare health outcomes. Clinical trials are also for patients at all different stages of their diagnosis. Depending on the specific study, the patient may receive access to a new cutting-edge treatment before it is widely available. When patients join a clinical trial, the research team becomes a health partner dedicated to their health and well-being. When patients join a clinical trial, they make an informed decision in their healthcare by weighing all available options in addition to routine treatments. Research participants know that they are contributing meaningfully and helping other patients like them. Where can I find more information about clinical trials at Renown Health? Renown Health’s mission is to make a genuine difference in the health and well-being of the communities we serve. Renown’s clinical trial portfolio offers leading care options to patients in northern Nevada, close to home, in a variety of specialties. Contact the Renown Clinical Research Office for more information on clinical trials available to you!

    Read More About What Does It Mean to Participate in a Clinical Trial?

    • Atención del cáncer
    • Testimonio de paciente
    • Ensayos clínicos

    Un diagnóstico de cáncer y una mudanza a Reno

    Michael Millman was all set to move to Reno from the Bay Area when he noticed a pimple-like growth on his forehead, and he decided to get biopsied "just in case." It was July 2020, less than six months into the COVID-19 pandemic, when Michael got the call that the biopsy came back cancerous. He was in shock. Still living in the Bay Area at the time, he immediately scheduled to have the basal cell carcinoma removed in August. After the removal, he thought he was in the clear, but a few months later, Michael noticed that his lymph nodes felt weird, and he even cut himself shaving because of some persistent swelling in the area. Given his recent history of skin cancer, Michael immediately scheduled an appointment with a specialist in the Bay Area. "I met with an ear, nose and throat doctor who suggested a fine needle biopsy of my lymph nodes, tongue and an MRI, both with and without contrast," Michael said. "I remember feeling dreadful and that I couldn't believe this was happening yet again." A Hard Decision Michael's squamous cell carcinoma, determined by the pathology report to be significantly influenced by the HPV virus, had metastasized to his lymph nodes on both sides of his neck, and his doctor said it could be stage four cancer. He remembers feeling like he was in quicksand, unsure if he should follow through with his move to Reno, or stay in the Bay Area for treatment. By now, it was early December 2020, and hospitals in the Bay Area and across the world were at limited capacity due to COVID-19. But, in what Michael describes as a positive twist of fate, the San Francisco ear, nose and throat provider he had seen about his biopsy results mentioned that he knew many providers in the oncology department at Renown, including Abhinand Peddada, MD. The San Francisco provider called Dr. Peddada's office with a referral, and Michael even remembers that Renown called him to hear more about his diagnosis before he even got the chance to call them "To be honest, I was feeling shut out in the Bay Area, and Dr. Peddada said he could help me expedite the treatment process," Michael said. "I finally felt a sense of relief." And so began Michael's 7-week chemoradiation cancer treatment program at Renown.

    Read More About A Cancer Diagnosis and a Move to Reno

    • Atención de apoyo y cuidados paliativos
    • Directiva anticipada
    • Atención médica para pacientes terminales

    Planifique con anticipación: Cómo completar su directiva anticipada

    We plan for the birth of a child, weddings and retirement, but rarely do we discuss how we want to be cared for at the end of our lives. Getting through this challenging conversation and completing an Advance Directive can give you peace of mind that your loved ones will not have to make difficult choices on your behalf. The best time to complete an Advance Directive is now – don’t wait until a life-limiting illness or crisis occurs to discuss your views about end-of-life care and to learn what choices are available. By preparing in advance, you can help reduce the doubt and anxiety related to decision-making for your family if you cannot speak for yourself. What are Advance Directives? An Advance Directive is a document that states your choices about medical treatment and names another person to make medical decisions on your behalf if you are unable to. This document allows you to make legally valid decisions about future medical care.  “Completing your Advance Directive is a gift you give your family,” says Director of Palliative Care, Mary-Ann Brown RN, MSN. “The stress associated with these difficult decisions is decreased if everyone knows what is important to you and what you want at the end of life.”

    Read More About Plan Early: Completing Your Advance Directive

Número de resultados encontrados: 26
Use esta navegación adicional para ir a las páginas siguientes. Use las teclas de tabulación e Intro para navegar por el menú1 Página n.º 2 Página n.º 3 Navegar a la página siguiente Página 1 de 3
Saltee a 26 resultados encontrados. Página 1 de 3